This phase I trial evaluates whether adding Pedmark to standard of care cisplatin-based chemotherapy reduces drug-induced ear damage (ototoxicity) in men with …

Hearing LossMetastatic Malignant Germ Cell TumorMetastatic Malignant Nongerminomatous Germ Cell Tumor+4 more

~Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07218913

Phase 2

Randomized Phase 2 Trial of Maintenance Oral Etoposide or Observation Following High-dose Chemotherapy for Relapsed Metastatic Germ-Cell Tumor

This is an open label randomized phase II trial of maintenance oral etoposide vs. observation in patinets with relapsed GCT treated with high-dose chemotherapy…

Germ Cell TumorNon-seminomatous Germ Cell TumorOvarian Germ Cell Tumor

~Estimated

~$10 – $7,500

Nabil AdraNCT04804007